Intravitreal Ganciclovir Concentration after Intravenous Administration in AIDS Patients with Cytomegalovirus Retinitis: Implications for Therapy

Journal of Infectious Diseases

Volumn 168, Issue 6, 1993, Pages 1506-1509

  Freeman, William R ^a   Kuppermann, Baruch D ^a,b   Quiceno, Jose I ^a   Aguilar, Marisa Flores ^a   Connor, James D ^a   Capparelli, Edmund V ^a   Sherwood, Charles H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINITIS; VITREOUS BODY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOMEGALOVIRUS RETINITIS; FEMALE; GANCICLOVIR; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; REGRESSION ANALYSIS; RETINAL DETACHMENT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VITREOUS BODY;

EID: 0027420685     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/168.6.1506     Document Type: Article

References (15)

1. Studies of the Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group, Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis, N Engl J Med 1992; 326: 213-20.
2. Palestine AG, Stevens G Jr, Lane HC, et al, Treatment ofcytomegalovirus retinitis with dihydroxy propoxymethyl guanine, Am J Ophthalmol 1986; 101 95-101.
3. Jabs DA, Newman C, De Bustros S, Polk BF, Treatment ofcytomegalovirus retinitis with ganciclovir, Ophthalmology 1987; 94: 824-30.
4. Henderly DE, Freeman WR, Causey DM, Rao NA, Cytomegalovirus retinitis and response to therapy with ganciclovir, Ophthalmology 1987; 94: 425-34.
5. LeHoang P, Girard B, Robinet M, et al, Foscamet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome, Ophthalmology 1989; 96: 865-73.
6. Gross JG, Bozzette SA, Mathews WE. et al, Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome, Ophthalmology 1990; 97: 681-6.
7. Drew WL, Miner RC, Busch DF, et al, Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection, J Infect Dis 1991; 163: 716-9.
8. Freeman WR, Quiceno JJ, Crapotta JA, Listhaus A, Munguia D, Flores-Aguilar M, Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis, Ophthalmology 1992; 99: 466-74.
9. Plotkin SA, Drew WL, Felsenstein D, Hirsch MS, Sensitivities ofclinical isolates of human cytomegalovirus to 9-(I, 3-dihydroxy-2-propoxymethyl) guanine, J Infect Dis 1985; 152: 833-4.
10. Jabs DA, Wingard JR, De Bustros S, De Miranda P, Saral R, Santos GW, BW B759U for cytomegalovirus retinitis: intraocular drug penetration, Arch Ophthalmol 1986; 104: 1436-7.
11. Stanat SC, Reardon JE, Erice A, Jordan MC, Drew WL, Biron K, Ganciclovir-resistant cytomegalovirus clinical isolates: mode ofresistance to ganciclovir, Antimicrob Agents Chemother 1991; 35: 2191-7.
12. Drew WL, Clinical use ofganciclovir for cytomegalovirus infection and the development of drug resistance, J Acquir Immune Defic Syndr 1991; 4: S42-6.
13. Abel R Jr, Boyle GL, Furman M, Leopold IH, Intraocular penetration of cefazolin sodium in rabbits, Am J Ophthalmol 1974; 78: 779-87.
14. Martin OF, Ficker LA, Aguilar HA, Gardner SK, Wilson LA, Meredith TA, Vitreous cefazolin levels after intravenous injection: effects of inflammation, repeated antibiotic doses, and surgery, Arch Ophthalmol 1990; 108: 411-4.
15. Bartsch DU, Bille JF, Dreher AW, Intaglietta M, Gharib M, Freeman WR, Analysis of the human macula by confocal laser tomography, In: Nasemann JE, Burk ROW, eds, Scanning laser ophthalmoscopy and tomography, Munich: Quintessenz, 1990: 215-23.